Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 9/20 | 0.70 |
| ▸ | HTR2C | P28335 | 7/20 | 0.70 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.70 |
| ▸ | HTR2B | P41595 | 5/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.47 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.47 |
| ▸ | HTR1B | P28222 | 1/20 | 0.47 |
| ▸ | HTR7 | P34969 | 1/20 | 0.47 |
| ▸ | HTR6 | P50406 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24959990 | 0.85 | HTR2A (0.68) | HTR2AHTR2CTAAR1HTR2BADRA1A | |
| SCHEMBL29351348 | 0.82 | HTR2A (1.00) | HTR2AHTR2CTAAR1HTR2B | |
| SCHEMBL23478 | 0.82 | HTR2A (1.00) | HTR2AHTR2CTAAR1HTR2B | |
| SCHEMBL5809547 | 0.82 | HTR2A (1.00) | HTR2AHTR2CTAAR1HTR2B | |
| Hydrochloric Acid SCHEMBL22614747 | 0.81 | HTR2A (0.96) | HTR2AHTR2CTAAR1HTR2B | |
| Methane SCHEMBL20703126 | 0.81 | HTR2A (0.96) | HTR2AHTR2CTAAR1HTR2B | |
| Hydrochloric Acid SCHEMBL25285317 | 0.81 | HTR2A (0.96) | HTR2AHTR2CTAAR1HTR2B | |
| SCHEMBL31456014 | 0.81 | HTR2A (0.66) | HTR2AHTR2CTAAR1HTR2B | |
| SCHEMBL244435 | 0.80 | HTR2A (0.76) | HTR2AHTR2CTAAR1HTR2BADRA1A | |
| SCHEMBL10049625 | 0.80 | HTR2A (0.48) | HTR2AHTR2CTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250353808-A1 | 5-METHOXYMETHYL AND 5-HYDROXYMETHYL PHENETHYLAMINES | 2A BIOSCIENCES, INC. | 2025-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353808-A1 | 5-METHOXYMETHYL AND 5-HYDROXYMETHYL PHENETHYLAMINES | HTR5A, PNMT, HTR6 | HTR2A 8/4885HTR2C 7/4885TAAR1 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.